top of page
Search
  • Writer's pictureskinwfa

Biologics in Treating Psoriasis

Written by Nisha Evangelista

Overview

Psoriasis is a chronic autoimmune condition characterized by red, scaly patches on the skin. This condition affects millions worldwide. Fortunately, recent advancements in dermatology have revolutionized treatment options, particularly with the introduction of biologic therapies tailored to manage symptoms effectively.


Symptoms of Psoriasis

Some common symptoms of psoriasis include:

1. Red Patches of Skin: These patches are often covered with thick, silvery-white scales. They can appear anywhere on the body, but are commonly found on the elbows, knees, scalp, and lower back.


2. Dry, Cracked Skin: The skin may be dry and cracked, and it can sometimes bleed.


3. Itching, Burning, or Soreness: The affected areas can be itchy, burn, or be sore.


4. Thickened, Pitted, or Ridged Nails: Psoriasis can also affect the nails, leading to changes in the nail structure and appearance.


5. Swollen and Stiff Joints: Some people with psoriasis develop psoriatic arthritis, which causes swollen, painful, and stiff joints.


6. Small Scaling Spots: These are typically seen in children and are usually triggered by a bacterial infection such as strep throat.


Traditional Psoriasis Treatments

Some traditional treatments for psoriasis include topical creams, oral medications, and phototherapy. These are proven to be effective for most, but while these treatments can provide relief, they may not be effective for all patients. Moreover, these treatments often come with side effects such as skin irritation or systemic impacts.


Biologic Therapies

Biologic therapies offer a targeted approach by addressing specific immune responses involved in psoriasis development. They are designed to inhibit cytokines such as tumor necrosis factor-alpha (TNF-alpha) or interleukins (IL) 12 and 23, which play key roles in the inflammatory pathways leading to psoriatic lesions.


Common biologics used in psoriasis treatment include TNF-alpha inhibitors like adalimumab and etanercept, IL-12/23 inhibitors such as ustekinumab, and IL-17 inhibitors like secukinumab and ixekizumab. These medications are administered either through self-injection or infusion under medical supervision, depending on the specific biologic and patient preference.


Efficacy of Biologic Therapies

These biologic therapies and their efficacy are well-documented with many patients experiencing significant improvements in symptoms and their quality of life. Clinical studies have shown that biologics not only reduce the severity and length of psoriatic lesions but also help maintain long-term inactivity and prevent disease progression.


Despite their effectiveness, biologic therapies are not without considerations. They can be expensive, requiring insurance coverage or financial assistance programs for affordability. Additionally, regular monitoring for potential side effects such as infections or allergic reactions is essential during treatment.


Conclusion

In conclusion, biologic therapies represent a promising advancement in dermatology, offering targeted treatment options for individuals with moderate to severe psoriasis who have not responded adequately to traditional therapies. Collaboration between dermatologists and patients in selecting the most suitable treatment plan ensures optimal outcomes and improved quality of life for those living with psoriasis.

Citations:


Disclaimer: Everything posted on our website and Instagram is intended for basic educational purposes only. If you suspect you have symptoms of any condition, it is essential to consult a dermatologist or your healthcare provider for a proper diagnosis and treatment plan. Our content is not a substitute for professional medical care.

2 views0 comments

Comments


bottom of page